Early laparoscopic cholecystectomy by a dedicated emergency surgical unit confers excellent outcomes in acute cholecystitis presenting beyond 72 hours

ANZ J Surg. 2019 Nov;89(11):1446-1450. doi: 10.1111/ans.15398. Epub 2019 Sep 3.

Abstract

Background: Early laparoscopic cholecystectomy (ELC) within 72 h of symptom onset is preferred for management of acute cholecystitis (AC). Beyond 72 h, acute-on-chronic fibrosis sets in rendering surgery challenging. This study aims to compare the outcomes of ELC for AC within and beyond 72 h of symptom onset by a dedicated acute surgical unit.

Methods: This is a single-centre retrospective study of 217 patients with AC who underwent ELC by an acute surgical unit from January 2017 to August 2018. Outcomes collected include post-operative morbidity, length of hospitalization and operation duration. A subgroup analysis for the same outcomes was performed for elderly patients.

Results: Of the 217 patients, 88 were operated within 72 h of symptom onset while 129 were operated beyond 72 h. Twenty-six patients received ELC after 7 days. There was no occurrence of bile duct injury. There was no statistical difference in conversion rates, wound infections and post-operative collections. Patients receiving ELC beyond 72 h had longer duration of operation (125.4 versus 116 min, P = 0.035) and length of hospitalization (4.59 versus 3.09 days, P = 0.001) without increase in morbidity. Patients older than 75 years had a higher incidence of post-operative collection (P < 0.001).

Conclusion: Patients with AC undergoing ELC by a dedicated acute surgical unit can have good outcomes even beyond 72 h of symptom onset. Meticulous haemostasis should be performed for the elderly subgroup of patients.

Keywords: 72 hours; acute cholecystitis; acute surgical unit; early laparoscopic cholecystectomy.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Cholecystectomy, Laparoscopic*
  • Cholecystitis, Acute / surgery*
  • Emergency Service, Hospital
  • Emergency Treatment
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Time-to-Treatment*
  • Treatment Outcome